Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 9Cholangiocarcinoma 8Pancreatic Neoplasms 7Gallbladder Neoplasms 6Ovarian Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Rectal Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Klatskin Tumor 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rhabdomyosarcoma 1Resectable Intrahepatic Cholangiocarcinoma 1Recurrence 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1PRETEXT I Hepatoblastoma 1Mesothelioma, Malignant 1Liposarcoma 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Fibrolamellar hepatocellular carcinoma 1

Interventions

apatinib 2tyrosyl-glutamyl-tryptophan 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Esophagus Cancer × Platinum × Gastrointestinal × Clear all
NCT03542422 2018-06-14

Apatinib as First -Line Treatment for Advanced Esophagus Cancer

Affiliated Hospital of North Sichuan Medical College

Phase 2 Unknown
50 enrolled
Gastrointestinal

Advanced Esophagus Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡